Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTLL10 antisense RNA 1 (TTLL10-AS1) is a long non-coding RNA gene located antisense to the TTLL10 protein-coding gene. It belongs to the lncRNA molecular class, and available data show its association with congenital myasthenic syndrome. The biological function of TTLL10-AS1 is not well described; it is presumed to have a regulatory role in gene expression, as is typical for lncRNAs, but specific mechanisms or clinical implications have not been established. TTLL10-AS1 is not considered a classical therapeutic target such as a receptor or enzyme, and no drugs or biomarkers are linked to it[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TTLL10 antisense RNA 1 (TTLL10-AS1).